Revenue Update on Neogen Corporation(NASDAQ:NEOG)

Neogen Corporation(NASDAQ:NEOG) announced the earnings results for Fiscal Year 2017 and Q1. The results came in during Pre-market on Sep 27, 2016. Company reported revenue of $83.64M. Analysts estimated a revenue of $86.84M. Earnings per share were $0.26. Analysts had estimated an EPS of $0.26.

Neogen Corporation (NEOG) made into the market gainers list on Fridays trading session with the shares advancing 3.69% or 1.99 points. Due to strong positive momentum, the stock ended at $55.94, which is also near the day’s high of $56.22. The stock began the session at $54 and the volume stood at 2,11,414 shares. The 52-week high of the shares is $61.24 and the 52 week low is $43. The company has a current market capitalization of $2,102 M and it has 3,75,74,890 shares in outstanding.

Several Insider Transactions has been reported to the SEC. On Aug 25, 2016, Richard E Jr Calk (President & COO) sold 5,425 shares at $57.47 per share price.Also, On Aug 12, 2016, Jack C Parnell (director) sold 5,000 shares at $56.87 per share price.On Aug 11, 2016, James L Herbert (Chairman & CEO) sold 6,068 shares at $55.60 per share price, according to the Form-4 filing with the securities and exchange commission.

Neogen Corporation develops manufactures and markets a diverse line of products dedicated to food and animal safety. The Company has two segments: Food Safety and Animal Safety. The Food Safety segment is engaged in the development production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins foodborne bacteria allergens and levels of general sanitation. The Animal Safety segment is engaged in the development production and marketing of products dedicated to animal safety including a complete line of consumable products marketed to veterinarians and animal health product distributors. It also provides genomic identification and related interpretive bioinformatics services. Additionally the Animal Safety segment produces and markets rodenticides disinfectants and insecticides to assist in control of rodents insects and disease in and around agricultural food production and other facilities.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Neogen Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Neogen Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.